epirubicin has been researched along with Shock, Septic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baltimore, D; Chora, A; Costa, P; Döring, G; Faridi, H; Ferreira, JA; Figueiredo, N; Gama-Carvalho, M; Gozzelino, R; Green, DR; Grompe, M; Gupta, V; Hartleben, B; Huber, TB; Marques, S; Martinez, J; Moita, C; Moita, LF; Neves-Costa, A; Pedroso, D; Pejanovic, N; Pereira, P; Pinto, A; Raquel, H; Simas, JP; Soares, MP; Zhang, Q; Zhao, JL | 1 |
1 other study(ies) available for epirubicin and Shock, Septic
Article | Year |
---|---|
Anthracyclines induce DNA damage response-mediated protection against severe sepsis.
Topics: Adenoviridae Infections; Animals; Anthracyclines; Anti-Bacterial Agents; Ataxia Telangiectasia Mutated Proteins; Autophagy-Related Protein 7; Cecum; DNA Damage; DNA Repair; Epirubicin; Fanconi Anemia Complementation Group D2 Protein; Inflammation; Inflammation Mediators; Injections, Intraperitoneal; Lung; Meropenem; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; Organ Specificity; Peritonitis; Respiratory Tract Infections; Sepsis; Shock, Septic; Thienamycins; Whole-Body Irradiation | 2013 |